Search

Author/Creator Abe, N

1. 196PHGCSG1403: Phase I trial of oxaliplatin/irinotecan/S-1 (OX-IRIS) as first-line chemotherapy for unresectable pancreatic cancer. (25th November 2018)

Authors:
Yoshikawa, A; Kawamoto, Y; Yuki, S; Nakano, S; Sawada, K; Muranaka, T; Nakatsumi, H; Harada, K; Kobayashi, Y; Miyagishima, T; Saiki, T; Ishiguro, A; Saito, R; Ehira, N; Iwanaga, I; Hatanaka, K; Abe, N; Sakamoto, N; Sakata, Y; Komatsu, Y
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Impact of frailty on super elderly patients with peripheral artery disease from the I-PAD 3 year registry. (25th November 2020)

Authors:
Nishikawa, K; Nagae, A; Miura, T; Katoh, T; Kanzaki, Y; Abe, N; Yokota, D; Yanagisawa, T; Senda, K; Wakabayashi, T; Oyama, Y; Okina, Y; Nakazawa, S; Tsukada, S; Kagoshima, M
Journal:
European heart journal
Issue:
Volume 41:(2020)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗